Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 23 | 2020 | 1153 | 2.250 |
Why?
|
| Bronchiolitis Obliterans | 9 | 2014 | 192 | 1.700 |
Why?
|
| Cystic Fibrosis | 17 | 2024 | 1177 | 1.400 |
Why?
|
| Delayed Graft Function | 1 | 2019 | 48 | 0.660 |
Why?
|
| Trachea | 7 | 2005 | 1076 | 0.520 |
Why?
|
| Graft Rejection | 9 | 2018 | 4397 | 0.470 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2013 | 523 | 0.430 |
Why?
|
| Mannose-Binding Lectin | 1 | 2012 | 150 | 0.390 |
Why?
|
| Herpesvirus 4, Human | 2 | 2013 | 1041 | 0.330 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 741 | 0.330 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2013 | 570 | 0.300 |
Why?
|
| HLA Antigens | 2 | 2010 | 1381 | 0.290 |
Why?
|
| Stem Cell Transplantation | 2 | 2006 | 1620 | 0.280 |
Why?
|
| Graft Survival | 4 | 2018 | 3737 | 0.270 |
Why?
|
| Cyclosporine | 2 | 2005 | 786 | 0.260 |
Why?
|
| Lung Diseases | 3 | 2006 | 1886 | 0.260 |
Why?
|
| Respiratory Mucosa | 4 | 2014 | 427 | 0.260 |
Why?
|
| Antibodies | 1 | 2013 | 2460 | 0.240 |
Why?
|
| Hyperglycemia | 2 | 2024 | 1373 | 0.240 |
Why?
|
| Achromobacter | 1 | 2022 | 7 | 0.230 |
Why?
|
| Transplantation, Heterotopic | 1 | 2002 | 175 | 0.210 |
Why?
|
| Stem Cells | 2 | 2006 | 3567 | 0.200 |
Why?
|
| Transplantation Immunology | 2 | 2003 | 546 | 0.200 |
Why?
|
| Aminophenols | 1 | 2021 | 78 | 0.190 |
Why?
|
| Growth Substances | 1 | 2002 | 784 | 0.180 |
Why?
|
| Bacteriophages | 1 | 2022 | 356 | 0.180 |
Why?
|
| Cell Division | 2 | 2005 | 4568 | 0.160 |
Why?
|
| Transplantation, Homologous | 7 | 2010 | 4776 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 1537 | 0.160 |
Why?
|
| Quinolones | 1 | 2021 | 367 | 0.150 |
Why?
|
| Epithelium | 1 | 2002 | 1679 | 0.150 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3528 | 0.150 |
Why?
|
| Patient Care Management | 1 | 2020 | 306 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2024 | 861 | 0.140 |
Why?
|
| Airway Management | 1 | 2020 | 329 | 0.140 |
Why?
|
| Transplantation, Isogeneic | 3 | 2002 | 257 | 0.140 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2024 | 434 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 2 | 2018 | 530 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2014 | 4217 | 0.130 |
Why?
|
| Bone Density | 4 | 2021 | 3468 | 0.120 |
Why?
|
| Bone and Bones | 2 | 2021 | 2575 | 0.110 |
Why?
|
| Regeneration | 1 | 2002 | 1485 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 7 | 2006 | 6386 | 0.110 |
Why?
|
| Lymphocytes | 4 | 2014 | 2617 | 0.110 |
Why?
|
| Lung | 3 | 2006 | 9856 | 0.110 |
Why?
|
| Cold Ischemia | 1 | 2012 | 65 | 0.100 |
Why?
|
| HLA-A Antigens | 2 | 2010 | 231 | 0.100 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2012 | 91 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 1838 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2013 | 15295 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 491 | 0.090 |
Why?
|
| Bone Diseases, Endocrine | 1 | 2009 | 2 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2019 | 9146 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 3336 | 0.080 |
Why?
|
| HLA-A3 Antigen | 1 | 2008 | 34 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 645 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2013 | 652 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4751 | 0.080 |
Why?
|
| Quality of Life | 2 | 2020 | 12804 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.080 |
Why?
|
| Palliative Care | 2 | 2020 | 3493 | 0.070 |
Why?
|
| Critical Care | 1 | 2020 | 2647 | 0.070 |
Why?
|
| Cytokines | 3 | 2006 | 7322 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3229 | 0.070 |
Why?
|
| Bronchi | 2 | 2014 | 840 | 0.070 |
Why?
|
| Lung Injury | 1 | 2012 | 436 | 0.070 |
Why?
|
| Propionibacterium acnes | 1 | 2006 | 66 | 0.070 |
Why?
|
| Humans | 31 | 2024 | 744343 | 0.070 |
Why?
|
| Phenotype | 2 | 2019 | 16365 | 0.070 |
Why?
|
| Apoptosis | 1 | 2002 | 9727 | 0.070 |
Why?
|
| Immunosuppressive Agents | 3 | 2004 | 4149 | 0.070 |
Why?
|
| Osteocalcin | 2 | 2003 | 273 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 5751 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2013 | 2240 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2024 | 6256 | 0.060 |
Why?
|
| Adult | 18 | 2024 | 214055 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2010 | 1366 | 0.060 |
Why?
|
| Bionics | 1 | 2024 | 42 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 21827 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2005 | 526 | 0.060 |
Why?
|
| Mice | 11 | 2014 | 81183 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2006 | 341 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2006 | 316 | 0.060 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2004 | 144 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2014 | 19229 | 0.050 |
Why?
|
| Animals | 13 | 2014 | 168757 | 0.050 |
Why?
|
| Alendronate | 1 | 2003 | 171 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2019 | 4558 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2765 | 0.050 |
Why?
|
| Insulin Infusion Systems | 1 | 2024 | 212 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3690 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2225 | 0.050 |
Why?
|
| Safety | 1 | 2006 | 1186 | 0.050 |
Why?
|
| Osteoporosis | 2 | 2003 | 1580 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 595 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 810 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2010 | 2119 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2021 | 40561 | 0.040 |
Why?
|
| Male | 16 | 2021 | 350118 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2645 | 0.040 |
Why?
|
| Models, Biological | 2 | 2005 | 9583 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 437 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1998 | 719 | 0.040 |
Why?
|
| Adolescent | 8 | 2021 | 85781 | 0.040 |
Why?
|
| Female | 16 | 2021 | 380194 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1022 | 0.040 |
Why?
|
| Pancreas | 1 | 2024 | 1686 | 0.040 |
Why?
|
| Forecasting | 1 | 2006 | 2951 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.040 |
Why?
|
| Survival Rate | 1 | 2010 | 12788 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2006 | 5078 | 0.030 |
Why?
|
| Rabbits | 1 | 2002 | 4894 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2004 | 18029 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4251 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11366 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5974 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1743 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6473 | 0.030 |
Why?
|
| Tenascin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 128 | 0.030 |
Why?
|
| Respiratory System | 1 | 1997 | 557 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2018 | 77449 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2006 | 3386 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 961 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2969 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1998 | 2716 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 964 | 0.030 |
Why?
|
| Patient Preference | 1 | 2020 | 890 | 0.030 |
Why?
|
| Advance Care Planning | 1 | 2020 | 662 | 0.030 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10252 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 2564 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 2872 | 0.020 |
Why?
|
| Pleura | 1 | 2012 | 235 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4560 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 644 | 0.020 |
Why?
|
| Insulin | 1 | 2024 | 6580 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.020 |
Why?
|
| Macrophages | 2 | 2006 | 5655 | 0.020 |
Why?
|
| Collagen | 2 | 2012 | 2689 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11483 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 2576 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1998 | 4026 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21746 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 40075 | 0.020 |
Why?
|
| Bacteria | 1 | 1997 | 2114 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15540 | 0.020 |
Why?
|
| Succinimides | 1 | 2005 | 79 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2005 | 235 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18370 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3176 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3019 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7181 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 365 | 0.020 |
Why?
|
| Vitamin K Deficiency | 1 | 2003 | 24 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 768 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 156 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
| Animals, Wild | 1 | 2002 | 90 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2006 | 592 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 315 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2024 | 53288 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 35136 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 2003 | 353 | 0.010 |
Why?
|
| Chemokines | 1 | 2006 | 970 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 1616 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2018 | 23338 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2006 | 1057 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 793 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2002 | 886 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2003 | 723 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2002 | 936 | 0.010 |
Why?
|
| Viral Load | 1 | 2008 | 3299 | 0.010 |
Why?
|
| Depression | 1 | 2019 | 7766 | 0.010 |
Why?
|
| Inflammation | 1 | 1998 | 10638 | 0.010 |
Why?
|
| Adipokines | 1 | 2000 | 319 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 1821 | 0.010 |
Why?
|
| Lectins | 1 | 2000 | 513 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2505 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2009 | 1947 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1917 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2000 | 592 | 0.010 |
Why?
|
| Burkholderia cepacia | 1 | 1997 | 22 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2618 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 4982 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1997 | 252 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 3913 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4933 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6365 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 1736 | 0.010 |
Why?
|
| Fractures, Spontaneous | 1 | 1996 | 230 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2000 | 2263 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7279 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15076 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1997 | 639 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1997 | 1486 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2002 | 4386 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1997 | 1219 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12026 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2002 | 4479 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2000 | 3778 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1401 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 4409 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2569 | 0.000 |
Why?
|
| Length of Stay | 1 | 1997 | 6309 | 0.000 |
Why?
|
| Risk Factors | 2 | 2003 | 72290 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39050 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1996 | 25043 | 0.000 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_